Managing patients on direct factor Xa inhibitors with rapid thrombelastography

References

• Sennesael AL, Larock AS, Douxfils J, et al. Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study. Thromb J. 2018;16:28.
   PubMed Web of Science ®Google Scholar
• Janczak DT, Mimier MK, McBane RD, et al. Rivaroxaban and apixaban for initial treatment of acute venous thromboembolism of atypical location. Mayo Clin Proc. 2018;93(1):40–47.
   PubMed Web of Science ®Google Scholar
• Gadsboll K, Staerk L, Fosbol EL, et al. Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark. Eur Heart J. 2017;38(12):899–906.
   PubMed Web of Science ®Google Scholar
• Liesenfeld KH, Schafer HG, Troconiz IF, et al. Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis. Br J Clin Pharmacol. 2006;62(5):527–537.
   PubMed Web of Science ®Google Scholar
• van Es N, Coppens M, Schulman S, et al. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood. 2014;124(12):1968–1975.
   PubMed Web of Science ®Google Scholar
• Gomez-Outes A, Suarez-Gea ML, Lecumberri R, et al. Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives. Eur J Haematol. 2015;95(5):389–404.
   PubMed Web of Science ®Google Scholar
• Xarelto - summary of product characteristics [Internet]. Amsterdam: European Medicins Agency; c2013. Available from: https://www.ema.europa.eu/en/documents/product-information/xarelto-epar-product-information_en.pdf.
   Google Scholar
• Eliquis - summary of product characteristics [Internet]. Amsterdam: European Medicins Agency; c2013. Available from: https://www.ema.europa.eu/en/documents/product-information/eliquis-epar-product-information_en.pdf.
   Google Scholar
• Testa S, Legnani C, Tripodi A, et al. Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study. J Thromb Haemost. 2016;14(11):2194–2201.
   PubMed Web of Science ®Google Scholar
• Connors JM. Testing and monitoring direct oral anticoagulants. Blood. 2018;132(19):2009–2015.
   PubMed Web of Science ®Google Scholar
• Ebner M, Birschmann I, Peter A, et al. Limitations of specific coagulation tests for direct oral anticoagulants: a critical analysis. J Am Heart Assoc. 2018;7(19):e009807.
   PubMed Web of Science ®Google Scholar
• Allen GA, Monroe DM, 3rd, Roberts HR, et al. The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation. Blood Coagul Fibrinolysis. 2000;11(Suppl 1):S3–S7.
   PubMed Web of Science ®Google Scholar
• Johansson PI, Stensballe J, Oliveri R, et al. How I treat patients with massive hemorrhage. Blood. 2014;124(20):3052–3058.
   PubMed Web of Science ®Google Scholar
• Wikkelso A, Wetterslev J, Moller AM, et al. Thromboelastography (TEG) or rotational thromboelastometry (ROTEM) to monitor haemostatic treatment in bleeding patients: a systematic review with Meta-analysis and trial sequential analysis. Anaesthesia. 2017;72(4):519–531.
   PubMed Web of Science ®Google Scholar
• Holcomb JB, Minei KM, Scerbo ML, et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg. 2012;256(3):476–486.
   PubMed Web of Science ®Google Scholar
• Johansson PI. Goal-directed hemostatic resuscitation for massively bleeding patients: the copenhagen concept. Transfus Apher Sci. 2010;43(3):401–405.
   PubMed Web of Science ®Google Scholar
• Kobayashi LM, Brito A, Barmparas G, et al. Laboratory measures of coagulation among trauma patients on NOAs: results of the AAST-MIT. Trauma Surg Acute Care Open. 2018;3(1):e000231.
   PubMedGoogle Scholar
• Dias JD, Lopez-Espina CG, Ippolito J, et al. Rapid point-of-care detection and classification of direct-acting oral anticoagulants (DOACs) with the TEG(R) 6s: implications for trauma and acute care surgery. J Trauma Acute Care Surg. 2019;87(2):364–370.
   PubMed Web of Science ®Google Scholar
• Wikkelsø A, Wetterslev J, Møller AM, Afshari A. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD007871. doi: https://doi.org/10.1002/14651858.CD007871.pub3.
   Google Scholar
• Gonzalez E, Moore EE, Moore HB, et al. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg. 2016;263(6):1051–1059.
   PubMed Web of Science ®Google Scholar
• Bavalia R, Abdoellakhan R, Brinkman HJM, et al. Emergencies on direct oral anticoagulants: management, outcomes, and laboratory effects of prothrombin complex concentrate. Res Pract Thromb Haemost. 2020;4(4):569–581.
   PubMed Web of Science ®Google Scholar
• Smith MN, Deloney L, Carter C, et al. Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study. J Thromb Thrombolysis. 2019;48(2):250–255.
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Crowther M, Eikelboom JW, ANNEXA-4 Investigators, et al. Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. N Engl J Med. 2019;380(14):1326–1335.
   PubMed Web of Science ®Google Scholar
• Kashuk JL, Moore EE, Sabel A, et al. Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. Surgery. 2009;146(4):764–774.
   PubMed Web of Science ®Google Scholar
• Zacho M, Rafiq S, Kelbaek H, et al. Hypercoagulability in relation to coronary artery bypass graft patency and clinical outcome. Scand Cardiovasc J. 2013;47(2):104–108.
   PubMed Web of Science ®Google Scholar
• Testa S, Tripodi A, Legnani C, START-Laboratory Register, et al. Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics. Thromb Res. 2016;137:178–183.
   PubMed Web of Science ®Google Scholar
• Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a Meta-analysis of randomised trials. Lancet. 2014;383(9921):955–962.
   PubMed Web of Science ®Google Scholar
• Piran S, Schulman S. Treatment of bleeding complications in patients on anticoagulant therapy. Blood. 2019;133(5):425–435.
   PubMed Web of Science ®Google Scholar